Literature DB >> 25876276

Analysis of in vitro and in vivo effects of probiotics against Campylobacter spp.

Katharina Bratz, Greta Gölz, Pawel Janczyk, Karsten Nöckler, Thomas Alter.   

Abstract

Campylobacter (C.) spp. are well recognised as the leading cause of bacterial food-borne diarrheal disease worldwide, with C. jejuni and C. coli as the most important species: C. coli is highly abundant in pigs and pork meat has often been implicated as a source for human infection. Intestinal colonisation of C. coli in pigs plays a role in carcass contamination during slaughter. Different pre-harvest intervention measures are proposed to reduce the C. coli burden in the porcine intestine. Among others, the use of probiotics to prevent or reduce the colonisation of intestinal pathogens is discussed. One aim of this study was to screen a variety of probiotics to evaluate their inhibitory activity against Campylobacter spp. in vitro. Therefore, cell-free culture supernatants of Lactobacillus spp., Bifidobacterium spp., Enterococcus (E.) faecium NCIMB 10415, and Escherichia coli Nissle 1917 were tested against C. jejuni and C. coli by a well-diffusion agar assay. Seven out of eleven Lactobacillus strains showed an inhibitory activity against at least one of the three tested Campylobacter strains. This antagonistic activity against Campylobacter spp. was caused by the production of organic acids that lowered the pH. Application with pH neutralised cell-free culture supernatants abolished this inhibitory effect. Other tested strains with probiotic properties showed no inhibitory activity against any Campylobacter spp. strain. The strain E. faecium NCIMB 10415 was chosen to test its inhibitory activity against C. coli in vivo. Twenty weaned piglets were allocated into two groups, a probiotic group and a control group.The diet of the probiotic group was supplemented with E. faecium NCIMB 10415 (10(9) cfu/kg feed, Cylactin) since weaning, whereas the control group received no probiotic treatment. All piglets were naturally colonised with C. coli. The excretion load of C. coli was monitored for 28 days. The results indicate that dietary supplementation of E. faecium NCIMB 10415 did not significantly affect C. coli excretion levels in pigs. In this study, E. faecium NCIMB 10415 showed no antagonistic activity against C. coli in vitro and in vivo and had no impact on the growth performance of weaned piglets.

Entities:  

Mesh:

Year:  2015        PMID: 25876276

Source DB:  PubMed          Journal:  Berl Munch Tierarztl Wochenschr        ISSN: 0005-9366            Impact factor:   0.328


  7 in total

Review 1.  Recent Advances in Screening of Anti-Campylobacter Activity in Probiotics for Use in Poultry.

Authors:  Manuel J Saint-Cyr; Muriel Guyard-Nicodème; Soumaya Messaoudi; Marianne Chemaly; Jean-Michel Cappelier; Xavier Dousset; Nabila Haddad
Journal:  Front Microbiol       Date:  2016-05-31       Impact factor: 5.640

Review 2.  Current and Potential Treatments for Reducing Campylobacter Colonization in Animal Hosts and Disease in Humans.

Authors:  Tylor J Johnson; Janette M Shank; Jeremiah G Johnson
Journal:  Front Microbiol       Date:  2017-03-23       Impact factor: 5.640

3.  Probiotic potential of Lactobacillus isolates of chicken origin with anti-Campylobacter activity.

Authors:  Marta Dec; Anna Nowaczek; Renata Urban-Chmiel; Dagmara Stępień-Pyśniak; Andrzej Wernicki
Journal:  J Vet Med Sci       Date:  2018-06-06       Impact factor: 1.267

Review 4.  Current Perspectives and Potential of Probiotics to Limit Foodborne Campylobacter in Poultry.

Authors:  Wenjun Deng; Dana K Dittoe; Hilary O Pavilidis; William E Chaney; Yichao Yang; Steven C Ricke
Journal:  Front Microbiol       Date:  2020-12-22       Impact factor: 5.640

Review 5.  The Role of Nutraceuticals and Phytonutrients in Chickens' Gastrointestinal Diseases.

Authors:  Lucia Biagini; Livio Galosi; Alessandra Roncarati; Anna-Rita Attili; Sara Mangiaterra; Giacomo Rossi
Journal:  Animals (Basel)       Date:  2022-03-31       Impact factor: 2.752

6.  In Vitro assessment of anti-Campylobacter activity of lactobacillus strains isolated from canine rectal swabs.

Authors:  Anna Tomusiak-Plebanek; Martyna Mruk; Sybilla Rząca; Magdalena Strus; Zbigniew Arent
Journal:  BMC Vet Res       Date:  2022-03-22       Impact factor: 2.741

7.  Nanobodies targeting conserved epitopes on the major outer membrane protein of Campylobacter as potential tools for control of Campylobacter colonization.

Authors:  Charlotte Vanmarsenille; Inés Díaz Del Olmo; Jelle Elseviers; Gholamreza Hassanzadeh Ghassabeh; Kristof Moonens; Didier Vertommen; An Martel; Freddy Haesebrouck; Frank Pasmans; Jean-Pierre Hernalsteens; Henri De Greve
Journal:  Vet Res       Date:  2017-12-08       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.